Search Results - Yanxin Liu
- Showing 1 - 10 results of 10
-
1
Synthesis and biological evaluation of new 13-n-nonylprotoberberine derivatives as antitubercular agents by Yinghong Li, Yanxin Liu, Yanxiang Wang, Sheng Tang, Danqing Song
Published 2013Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Exosomes: A Novel Therapeutic Agent for Cartilage and Bone Tissue Regeneration by Yanxin Liu, Yifan Ma, Jingjing Zhang, Yuan Yuan, Jinqiao Wang
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Cost-effectiveness analysis of olaparib as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation in china by Yamin Shu, Yanxin Liu, Xucheng He, Yufeng Ding, Qilin Zhang
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system by Yamin Shu, Xucheng He, Pan Wu, Yanxin Liu, Yufeng Ding, Qilin Zhang
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
SPARC activates p38γ signaling to promote PFKFB3 protein stabilization and contributes to keloid fibroblast glycolysis by Yining Liu, Wei Zhang, Nan Lin, Zelei Yang, Yanxin Liu, Huaxia Chen
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
6
Cost-effectiveness of osimertinib versus standard EGFR-TKI as first-line treatment for EGFR-mutated advanced non-small-cell lung cancer in China by Yamin Shu, Yufeng Ding, Xucheng He, Yanxin Liu, Pan Wu, Qilin Zhang
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
7
Fluoroquinolone-associated suspected tendonitis and tendon rupture: A pharmacovigilance analysis from 2016 to 2021 based on the FAERS database by Yamin Shu, Qilin Zhang, Xucheng He, Yanxin Liu, Pan Wu, Li Chen
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
8
Post-Marketing Safety Concerns With Secukinumab: A Disproportionality Analysis of the FDA Adverse Event Reporting System by Yamin Shu, Yufeng Ding, Yanxin Liu, Pan Wu, Xucheng He, Qilin Zhang
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
9
The incidence and risk factors analysis of acute kidney injury in hospitalized patients received diuretics: A single-center retrospective study by Ruiqiu Zhang, Yanxin Liu, Jia Cao, Jiahui Lao, Baobao Wang, Siwen Li, Xin Huang, Fang Tang, Xiao Li
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
10
The application of organoids in colorectal diseases by Yanxin Liu, Dongxu Wang, Yanhong Luan, Boqiang Tao, Qirong Li, Qiang Feng, Hengzong Zhou, Jianfeng Mu, Jinhai Yu
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book